Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. - Wikidata - wikimedia - TriplyDB

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

http://www.wikidata.org/entity/Q33943901

about

Canine parvovirus-like particles, a novel nanomaterial for tumor targeting Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Precision targeted therapy of ovarian cancer A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells.Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts Atomic force microscopy: a multifaceted tool to study membrane proteins and their interactions with ligands.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate.Recent trends in targeted anticancer prodrug and conjugate design.Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates [DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.Effect of Fe(3)O(4)-magnetic nanoparticles on acute exercise enhanced KCNQ(1) expression in mouse cardiac muscle TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cells Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.Prodrugs for improving tumor targetability and efficiency.Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity.Synthesis, characterization, and biological activity of poly(arginine)-derived cancer-targeting peptides in HepG2 liver cancer cells.Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy.Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery.Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal muscle of mice Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer.Polymeric core-shell nanoparticles for therapeutics.Polymer conjugates as anticancer nanomedicines.Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles.Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide.DUP1 peptide modified micelle efficiently targeted delivery paclitaxel and enhance mitochondrial apoptosis on PSMA-negative prostate cancer cells Polymer-drug conjugates as modulators of cellular apoptosis.Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.Cancer therapies utilizing the camptothecins: a review of the in vivo literature Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.

P2860

Q25256822-9C083DA9-0398-4038-BBAA-EE223B775463 Q27692125-3923C656-38BD-4BB7-86CD-6EC4E89C51B7 Q28078658-CC77A78A-6081-4018-A981-A772DED85301 Q28474508-E50F08B6-4285-4200-8173-FB32A210321B Q28486235-E99115A5-A4F4-4C78-B7DD-49610AAB1219 Q28538039-60F02952-DFAD-4779-A538-ED17744E2F73 Q28728340-9BD2A3C2-D234-44A1-A8E5-391A179F3727 Q30418509-2F175F9C-810D-440C-8934-527A1A45EA87 Q30421398-DD0EAD99-611F-4ADD-A7AE-40F2C3523AE2 Q30429625-21DA9BC0-E246-438E-A258-69B80DFC11C6 Q30456053-FCA04AF7-36BA-420D-A9DA-8604ED0E88A4 Q30830508-CA07CB21-7BB0-4494-AC11-1F3642EE6D14 Q33313432-1D3A8DAF-F3B8-48C9-8494-A464DCBFBDE4 Q33573762-5C411D4E-D11A-48F2-A234-D11DEBEEB545 Q33601744-D44D4F8C-B00C-41AE-BCF5-E5D23AA0A167 Q33724860-FB1ABE50-BA19-428A-B131-A040A496A647 Q33738469-7A747FAA-9D86-4563-883E-9AA9DB760E80 Q33769475-E286A2E2-A034-4567-B204-FE4A7EC7F895 Q33934763-7AB671B8-9AD5-4594-A3AF-8012CD1B391E Q34170191-710291DE-F127-4CD0-B566-07E8BDE581C9 Q34377387-2AEA8F5E-B9F7-48C4-B47E-660285F49FEF Q35095165-59C391C1-8032-4A72-8B47-9F5B4EE9FB71 Q35109017-4A57C9D6-62EC-4E6D-8581-0B3F4C11758E Q35188533-99564803-669B-46D2-BBEE-E88B1657519B Q35213029-0B504103-D007-4651-B2E9-301803B858DF Q35229094-ECBA39D2-D9F2-4B70-A8C8-EFCAEF24AFD2 Q35547515-36713490-5DDF-4189-8B6B-86017D078683 Q35591278-74244317-8D01-480D-9781-9825077DDBAE Q36070727-B2AFE214-DD7A-408F-9433-3531AFE66006 Q36177559-9592C71E-8C2E-44F4-A624-0BD68472392A Q36478861-C4AB7770-F4C8-49DF-AC84-EEEB2BD0DF35 Q36561667-9E88832F-ED00-4770-9E44-67A558A50247 Q36659125-306E4F78-48BC-4E66-B2D7-7F5261000D7A Q36662084-34F44F98-1258-48C5-9D38-1000F778B8D4 Q36687313-95585202-64FC-4D40-9553-A9706342282C Q36717609-A43C5359-2AF4-42A6-B222-1B684BED4476 Q36956674-01230F66-892C-43F4-A723-9688D269DA5C Q37067185-AEA96B8B-FEAD-4EC9-B76B-AF9107C8BE4A Q37069556-ADC57D15-B1DB-4129-8E12-EDDB7830387C Q37121611-14C30860-BFD8-48A2-9919-EB917DEB3475

P2860

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

http://www.wikidata.org/entity/Q33943901

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

@ast

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

@en

type

label

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

@ast

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

@en

prefLabel

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

@ast

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

@en

P1433

Q33943901-06998752-A851-4E97-B62F-CF2E94722A60

P1476

Q33943901-87FD2C5C-401A-467A-950D-267C114FA570

P2093

Q33943901-1A3B09CD-C763-4E84-9DE6-4220C49A7227

Q33943901-5C72B500-21B1-44C3-BA7C-B051DC4512F2

Q33943901-79BB119A-50C3-4693-B943-2B19E49FF73D

Q33943901-A6F63936-493F-4879-BC13-64A5B25E965C

Q33943901-ADFF4BA8-E965-4A1E-88F4-D3F3AD612A28

Q33943901-B0C02DF8-4A26-4303-A48F-7F4F43D02EE6

Q33943901-CEBD1EEF-02E9-423D-A402-06506A17D359

Q33943901-D08B79B1-D427-41F6-BA25-B735F1A17B22

Q33943901-E24B92FD-E709-4F53-A120-12B0C3605BEF

P2860

Q33943901-04D8EC63-8343-4D96-8EA5-C450D26D0BB8

Q33943901-252F68E3-ABC0-4C19-9D14-41F0D44A1D49

Q33943901-2AAD7CDE-3446-4439-9D78-C88E35F38A28

Q33943901-2B1EA48F-5BB1-4990-8C25-8239B9B074D0

Q33943901-30C5F8E9-E1A5-4967-B5FC-FF6B3EC19CCE

Q33943901-39D49877-AACE-4651-AFD4-80D6B03863EA

Q33943901-43B439BA-BE48-4FD7-92D6-57C2D8F233BA

Q33943901-48C7EAE3-577B-4411-A393-5E4E26CEF218

Q33943901-4FFE084E-7C14-4E03-B11C-2A74B1391FA0

Q33943901-50940F2B-E48B-473B-A912-69EAE282A92D

P304

Q33943901-6F86E6A0-2721-4C76-82CE-506C20D1F2D2

P31

Q33943901-7EEDADAD-CEAA-4A19-A442-573814894B4E

P356

Q33943901-1EC20430-0EE7-4A11-9F78-D6B034A09D1E

P407

Q33943901-BB61C4D0-E635-4AA3-8C32-A5D2A94EF307

P433

Q33943901-CA883D87-294A-4E57-AC17-C8007301DCA1

P478

Q33943901-E1153662-505D-4D53-B55F-05DCDDD9947B

P50

Q33943901-0E7BF039-1E44-40C4-B2C8-80A2B0D63447

P577

Q33943901-6B12AFF0-00C3-40A9-B237-B0D05F4A3310

P5875

Q33943901-8DBFA29D-4B05-41C1-9EA7-0388010FE6DD

P698

Q33943901-C09989D4-D027-4200-893C-9E345FAD9EB0

P921

Q33943901-6E04256B-472B-4A92-A0DD-1439EC19B432

P932

Q33943901-9977A068-5DCC-4882-823F-90939E16B74E

P356

PNAS.0504274102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide

@en

P2093

A Farmanfarmaian

http://www.w3.org/2001/XMLSchema#string

B Qiu

http://www.w3.org/2001/XMLSchema#string

J J Khandare

http://www.w3.org/2001/XMLSchema#string

P Chandna

http://www.w3.org/2001/XMLSchema#string

S Gunaseelan

http://www.w3.org/2001/XMLSchema#string

S S Dharap

http://www.w3.org/2001/XMLSchema#string

S Stein

http://www.w3.org/2001/XMLSchema#string

T Minko

http://www.w3.org/2001/XMLSchema#string

Y Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation

Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients

First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study.

Endogenous lectins as targets for drug delivery.

Polysaccharides in colon-specific drug delivery.

PEG drugs: an overview.

Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.

Circadian chemotherapy for gynecological and genitourinary cancers.

Polymerizable Fab' antibody fragments for targeting of anticancer drugs.

Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.

P304

12962-12967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0504274102

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Patrick J Sinko

P577

2005-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7637819

http://www.w3.org/2001/XMLSchema#string

P698

16123131

http://www.w3.org/2001/XMLSchema#string

P921

P932

1200279

http://www.w3.org/2001/XMLSchema#string